HSA & FSA accepted
Clinical Trial Results: The SURMOUNT Program Tirzepatides weight loss efficacy was established in the SURMOUNT phase 3 clinical trials
Follow-ups are done through the portal, where you can speak with a doctor to determine whether an adjustment to your medication is needed
Every bottle label carries a lot number that maps to a specific Certificate of Analysis
Matthew MYL, Naveed S, Rodica PB, Scott SE, Silvio EI, Johannes FEM, Nikolaus M, Sharon LM, Neil RP, Sunil VB, Richard EP, Vlado P, John BB, Darren KM
Why This Matters GLP-1 receptor agonists do more than help with weight loss.Theyve been shown to: Improve blood sugar control in type 2 diabetes Reduce cardiovascular risk Support long-term metabolic health But for many patients, cost has been a major barrier to starting or staying on therapy.If these new pricing initiatives take effect, more patients could finally access these medications safely and consistently under medical supervision